相关实验视频

Updated: Jun 24, 2025

Studying Left Ventricular Reverse Remodeling by Aortic Debanding in Rodents

Studying Left Ventricular Reverse Remodeling by Aortic Debanding in Rodents

Published on: July 14, 2021

循环RNA在病态心脏重塑中的调节作用

Alessia Bibi^1,2, Monika Bartekova^3,4, Shrey Gandhi^5,6

¹Molecular Cardiology Laboratory, IRCCS Policlinico San Donato, San Donato Milanese, Milan, Italy.

British journal of pharmacology

|June 3, 2024

概括

循环RNAs (circRNAs) 是心力衰竭发展中的关键调节者. 了解心脏重塑中的circRNA功能为新的心力衰竭诊断和治疗提供了潜力.

科学领域:

心血管生物学心血管生物学
分子遗传学分子遗传学
非编码RNA研究研究

背景情况:

心脏重塑,心脏受伤后心脏结构和分子变化的过程,导致心力衰竭.
循环RNAs (circRNAs) 正在成为包括心力衰竭在内的心血管疾病发病的关键调节者.

研究的目的:

审查目前关于circRNA生物学的知识,重点关注它们在心脏重塑中的作用.
探索基于circRNA的心力衰竭的诊断和治疗策略.

主要方法:

文献综述综合了目前关于心血管疾病中circRNAs的研究.
讨论生物信息学和用于circRNA研究的实验方法.
在关键的心脏重塑途径中突出circRNA调节功能.

主要成果:

循环RNA在心脏细胞死亡,缩,炎症,纤维化和新陈代谢中起着重要的作用.
该审查详细介绍了circRNA的起源,保存,特征和功能机制.
在心力衰竭的circRNA研究中确定了挑战和机遇.

结论:

更深入地了解心脏重塑中的circRNAs对于开发新型心力衰竭疗法至关重要.
循环RNAs作为潜在的治疗点和心力衰竭的生物标志物具有前景.
未来的研究应该集中在circRNAs的药理潜力上.

关键词:

生物标志物生物标志物进行心脏重塑.圆形的RNAs是圆形的RNAs.心脏衰竭是因为心脏衰竭.它具有治疗潜力.

更多相关视频

In Silico Identification and Characterization of circRNAs During Host-Pathogen Interactions

In Silico Identification and Characterization of circRNAs During Host-Pathogen Interactions

Published on: October 21, 2022

In Vivo Nanovector Delivery of a Heart-specific MicroRNA-sponge

In Vivo Nanovector Delivery of a Heart-specific MicroRNA-sponge

Published on: June 15, 2018

相关概念视频

Pathophysiology of Heart Failure

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...